Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles
Authors
Keywords
-
Journal
CANCER LETTERS
Volume -, Issue -, Pages 216462
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.canlet.2023.216462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment
- (2023) Zhiqing Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis
- (2023) Miles Piper et al. CANCER CELL
- Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
- (2023) Eun-Kyoung Koh et al. Scientific Reports
- The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
- (2023) Lincoln N. Strickland et al. Frontiers in Immunology
- Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice
- (2023) Kawaljit Kaur et al. Frontiers in Immunology
- A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases
- (2023) Miro E. Raeber et al. EBioMedicine
- Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report
- (2023) Xiaoting Ma et al. Frontiers in Oncology
- EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
- (2023) Loretah Chibaya et al. Nature Cancer
- Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer
- (2022) Kun-Yu Teng et al. GASTROENTEROLOGY
- Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model
- (2022) Sumit Kumar et al. GUT
- Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
- (2022) Samik Upadhaya et al. NATURE REVIEWS DRUG DISCOVERY
- iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
- (2022) Benjamin H. Goldenson et al. Frontiers in Immunology
- Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
- (2022) Thomas Walle et al. Science Advances
- Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer
- (2022) Jifan Chen et al. JOURNAL OF NANOBIOTECHNOLOGY
- STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
- (2022) Julia E Lefler et al. Life Science Alliance
- LncRNA NCAL1 potentiates natural killer cell cytotoxicity through the Gab2-PI3K-AKT pathway
- (2022) Chao Niu et al. Frontiers in Immunology
- Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer
- (2022) Dhifaf Sarhan et al. iScience
- CAR-NK cells: a promising cellular immunotherapy in lymphoma
- (2022) Shaghayegh Khanmohammadi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
- (2022) Christian L. Flugel et al. Nature Reviews Clinical Oncology
- Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
- (2022) Anurag Kumar Srivastava et al. Cancers
- Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
- (2021) Fang Sun et al. Advanced Science
- Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
- (2021) Yang Chen et al. CANCER CELL
- Photodynamic therapy exploiting the anti-tumor activity of mannose-conjugated chlorin e6 reduced M2-like tumor-associated macrophages
- (2021) Tatsuki Soyama et al. Translational Oncology
- Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles
- (2021) Qianwen Yu et al. Acta Biomaterialia
- Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen
- (2021) Adele Gabba et al. BIOCHEMISTRY
- Delivery technologies to engineer natural killer cells for cancer immunotherapy
- (2021) Rakan El-Mayta et al. CANCER GENE THERAPY
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
- (2021) Alireza Shokouhifar et al. Cancer Cell International
- T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
- (2021) Apostolia-Maria Tsimberidou et al. Journal of Hematology & Oncology
- Natural killer cells in pancreatic cancer stroma
- (2021) Rachel Elizabeth Ann Fincham et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
- (2021) Ellen N. Scott et al. Frontiers in Immunology
- Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma
- (2021) Virender Kumar et al. BIOMATERIALS
- Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
- (2021) Guy Biber et al. EMBO Molecular Medicine
- Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
- (2021) Friederike V. Opitz et al. Cancers
- Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review
- (2020) Cao Dai Phung et al. ARCHIVES OF PHARMACAL RESEARCH
- NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
- (2020) Stefano Regis et al. Frontiers in Immunology
- Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
- (2020) Alicia M Chenoweth et al. IMMUNOLOGY AND CELL BIOLOGY
- 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
- (2020) Nancy D. Ebelt et al. Frontiers in Immunology
- You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
- (2020) Aline Pfefferle et al. Cancers
- Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment
- (2020) Young Eun Lee et al. JOURNAL OF CONTROLLED RELEASE
- Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma
- (2020) Hee Seung Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy
- (2020) Kwang-Soo Kim et al. ACS Applied Materials & Interfaces
- Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer
- (2020) Jingjing Sun et al. BIOMATERIALS
- Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
- (2020) M.E. Lorkowski et al. JOURNAL OF CONTROLLED RELEASE
- Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities
- (2019) Vinod P. Balachandran et al. GASTROENTEROLOGY
- Early and late hematologic toxicity following CD19 CAR-T cells
- (2019) Shalev Fried et al. BONE MARROW TRANSPLANTATION
- Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
- (2019) Seon Ah Lim et al. Frontiers in Immunology
- Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer
- (2019) Eunsung Jun et al. Frontiers in Immunology
- Checkpoint inhibitors in pancreatic cancer
- (2019) Andreas Henriksen et al. CANCER TREATMENT REVIEWS
- CD8+CD28− T cells: key cytotoxic players impacting disease pathogenesis in chronic HBV infection
- (2019) Madhuparna Nandi et al. CLINICAL SCIENCE
- Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
- (2019) Akintunde Akinleye et al. Journal of Hematology & Oncology
- Robo1-specific CAR-NK Immunotherapy Enhances Efficacy of 125I Seed Brachytherapy in an Orthotopic Mouse Model of Human Pancreatic Carcinoma
- (2019) NING XIA et al. ANTICANCER RESEARCH
- Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
- (2019) Huang Zhu et al. BLOOD
- Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4/MAPKs/NF-κB pathway in vitro/vivo
- (2019) Xin Xie et al. CARBOHYDRATE POLYMERS
- Trans-endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation
- (2019) Olga M. Anton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer
- (2018) Mayumi Hoshikawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression
- (2018) Rika Fujii et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
- (2018) Virender Kumar et al. Theranostics
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells
- (2018) Yufeng Wang et al. NATURE IMMUNOLOGY
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
- (2017) M. Felices et al. GYNECOLOGIC ONCOLOGY
- Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer
- (2017) Mao Lin et al. IMMUNOLOGY LETTERS
- Recent progress in GM-CSF-based cancer immunotherapy
- (2017) Wan-Lun Yan et al. Immunotherapy
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma
- (2017) Qi Wu et al. Oncotarget
- The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis
- (2017) Geou-Yarh Liou et al. Cell Reports
- Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
- (2017) Anna Kozlowska et al. Journal of Cancer
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).
- (2017) R. F. Gabitass et al. JOURNAL OF CLINICAL ONCOLOGY
- The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
- (2017) Hirayuki Enomoto et al. Scientific Reports
- Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
- (2016) Virender Kumar et al. BIOMATERIALS
- IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
- (2016) Elizabeth L. McMichael et al. CLINICAL CANCER RESEARCH
- Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
- (2016) Jun-ichi Masuyama et al. CYTOTHERAPY
- Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages
- (2016) Qiaofei Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
- (2016) Xiansheng Lin et al. Oncotarget
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
- (2016) Takashi Nakamura et al. Scientific Reports
- Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
- (2015) Jeremiah L. Oyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer
- (2015) Goutam Mondal et al. BIOMACROMOLECULES
- Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
- (2015) A. Lo et al. CANCER RESEARCH
- Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
- (2015) S. Takeuchi et al. CANCER RESEARCH
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- PTEN Is a Negative Regulator of NK Cell Cytolytic Function
- (2015) Edward L. Briercheck et al. JOURNAL OF IMMUNOLOGY
- Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
- (2015) Andreas Heindl et al. LABORATORY INVESTIGATION
- Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
- (2015) Virender Kumar et al. MOLECULAR PHARMACEUTICS
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation
- (2015) Shaun Spence et al. Science Translational Medicine
- Adoptive cellular therapy: A race to the finish line
- (2015) Carl H. June et al. Science Translational Medicine
- IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
- (2015) Serena Lunardi et al. Oncotarget
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- Mutant KRAS–Induced Expression of ICAM-1 in Pancreatic Acinar Cells Causes Attraction of Macrophages to Expedite the Formation of Precancerous Lesions
- (2014) Geou-Yarh Liou et al. Cancer Discovery
- The Critical Role of IL-15–PI3K–mTOR Pathway in Natural Killer Cell Effector Functions
- (2014) Neethi Nandagopal et al. Frontiers in Immunology
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
- (2013) Abasi Ene–Obong et al. GASTROENTEROLOGY
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors
- (2013) Ilona Hromadnikova et al. MEDIATORS OF INFLAMMATION
- Pancreatic cancer-associated stellate cells
- (2013) Thomas A Mace et al. OncoImmunology
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
- (2012) R. Shakya et al. CANCER RESEARCH
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- DNA Methylation and Its Basic Function
- (2012) Lisa D Moore et al. NEUROPSYCHOPHARMACOLOGY
- High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer
- (2011) Dong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Unifying concepts of MHC-dependent natural killer cell education
- (2011) Julie M. Elliott et al. TRENDS IN IMMUNOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- NK cell education: not an on-off switch but a tunable rheostat
- (2009) Petter Brodin et al. TRENDS IN IMMUNOLOGY
- How Diverse--CD4 Effector T Cells and their Functions
- (2009) Y. Y. Wan et al. Journal of Molecular Cell Biology
- Beyond licensing and disarming: A quantitative view on NK-cell education
- (2008) Petter Brodin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor Crk
- (2008) Mary E. Peterson et al. IMMUNITY
- Memory CD4 T cells emerge from effector T-cell progenitors
- (2008) Laurie E. Harrington et al. NATURE
- Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
- (2008) A. M. Unni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now